Identification and characterization of ζ-opioid receptor in human colon cancer

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 271, Issue 1 40-1, 1996, Pages

  Hytrek, Staci D ^a   Smith, Jill P ^a   McGarrity, Thomas J ^a   McLaughlin, Patricia J ^a   Lang, C Max ^a   Zagon, Lan S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

HT 29; opioid growth factor; Met5 enkephalin

Indexed keywords

OPIATE RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CANCER GROWTH; CELLULAR DISTRIBUTION; COLON CANCER; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0029794341     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.271.1.r115     Document Type: Article

References (30)

1. Akil, H., S. J. Watson, E. Young, M. E. Lewis, H. Khatchaturian, and J. M. Walker. Endogenous opioids: biology and function. Annu. Rev. Neurosci. 7: 223-255, 1984.
2. Boland, C. R. The biology of colorectal cancer. Cancer 71, Suppl.: 4180-4186, 1993.
3. Boring, C. C., T. S. Squires, and T. Tong. Cancer statistics. CA Cancer J. Clin. 42: 19-38, 1992.
4. 50) of an enzyme reaction. Biochem. Pharmacol. 22: 3099-3108, 1973.
5. Faris, P. L., B. R. Komisaruk, L. R. Watkins, and D. J. Mayer. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science Wash. DC 219: 310-312, 1983.
6. Gross, J. L., W. F. Herblin, B. A. Dusak, P. Czerniak, M. D. Diamond, T. Sun, K. Eidsvoog, D. L. Dexter, and A. Yayon. Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. J. Natl. Cancer Inst. 85: 121-131, 1993.
7. Hytrek, S. D., C. M. Lang, P. J. McLaughlin, and I. S. Zagon. Characterization of the zeta (ζ) opioid receptor in human colon cancer (Abstract). FASEB J. 9: A703, 1995.
8. Hytrek, S. D., C. M. Lang, J. P. Smith, P. J. McLaughlin, and I. S. Zagon. Opioid growth, factor modulates tumorigenesis of human colon carcinoma grown in nude mice (Abstract). Gastroenterology 108: A483, 1995.
9. Iishi, H., M. Tatsuta, M. Baba, R. Yamamoto, and H. Taniguchi. Enhancement by bombesin of colon carcinogenesis and metastasis induced by azoxymethane in Wistar rats. Int. J. Cancer 50: 834-839, 1992.
10. Isayama, T., P. J. McLaughlin, and I. S. Zagon. Endogenous opioids regulate cell proliferation in the retina of developing rat. Brain Res. 544: 79-85, 1991.
11. Lahm, H., L. Suardet, P. L. Laurent, J. R. Fischer, A Ceyhan, J. C. Givel, and N. Odartchenko. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. Br. J. Cancer 65: 341-346, 1992.
12. Leslie, F. M. Methods used for the study of opioid receptors. Pharmacol. Rev. 39: 197-249, 1987.
13. 5]enkephalin. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R122-R129, 1996.
14. Murgo, A. J. Inhibition of B16-BL6 melanoma growth in mice by methionine-enkephalin. J. Natl. Cancer Inst. 75: 341-344, 1985.
15. Radulovic, S., G. Miller, and A. V. Schally. Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrm releasing peptide antagonist (RC-3095). Cancer Res. 51: 6006-6009, 1991.
16. Sassani, J. W., P. J. McLaughlin, and I. S. Zagon. Regulation of corneal epithelial wound healing in vitro by opioid growth factor (Abstract ). Invest. Ophthalmol. Visual Sci. 34: 1376, 1993.
17. Smith, J. P., and T. E. Solomon. Effects of gastrin, proglumide. and somatostatin on growth of human colon cancer. Gastroenterology 95: 1541-1548, 1988.
18. Wang, X.-J., and J.-S. Han. Modification by cholecytoskinin octapeptide of the binding of μ-, δ-, and κ-opioid receptors. J. Neurochem. 55: 1379-1382, 1990.
19. Zagon, I. S., D. M. Gibo, and P. J. McLaughlin. Zeta (ζ), a growth-related receptor in developing rat cerebellum: identification and characterization. Brain Res. 551: 28-35, 1991.
20. Zagon, I. S., S. R. Goodman, and P. J. McLaughlin. Demonstration and characterization of zeta (ζ), a growth-related opioid receptor, in a neuroblastoma cell line. Brain Res. 511: 181-186, 1990.
21. 5]enkephalin) prevents the incidence and retards the growth of human colon cancer. Am. J. Physiol. In press.
22. Zagon, I. S., and P. J. McLaughlin. Endogenous opioids and the growth regulation of a neural tumor. Life Sci. 43: 1313-1318, 1988.
23. Zagon, I. S., and P. J. McLaughlin. Endogenous opioid systems regulate growth of neural tumor cells in culture. Brain Res. 490: 14-25, 1989.
24. Zagon, I. S., and P. J. McLaughlin. Identification of opioid peptides regulating cell proliferation of neurons and glia in the developing nervous system. Brain Res. 542: 318-323, 1991.
25. Zagon, I. S., and P. J. McLaughlin. The role of endogenous opioids and opioid receptors in human and animal cancers. In: Stress and Immunity, edited by N. P. Plotnikoff, A. J. Murgo, R. E Faith, and J. Wybran. Caldwell, NJ: CRC, 1991, p. 343-356.
26. Zagon, I. S., and P. J. McLaughlin. Opioid growth factor receptor in the developing nervous system. In: Receptors in the Developing Nervous System. Growth Factors and Hormones, edited by I. S. Zagon and P. J. McLaughlin. London: Chapman & Hall, 1993, vol. 1, p. 39-62.
27. Zagon, I. S., P. J. McLaughlin, S. R. Goodman, and R. E. Rhodes. Opioid receptors and endogenous opioids in diverse human and animal cancers. J. Natl. Cancer Inst. 79: 1059-1065, 1987.
28. Zagon, I. S., P. J. McLaughlin, A. E. Takemori, and P. S. Portoghese. β-Funaltrexamine (β-FNA) and neural tumor response in mice. Eur. J. Pharmacol. 116: 165-169, 1985.
29. Zagon, I. S., Y. Wu, and P. J. McLaughlin. Opioid growth factor inhibits DNA synthesis in mouse tongue epithelium in a circadian rhythm-dependent manner. Am. J. Physiol. 267 (Regulatory Integrates Comp. Physiol. 36): R645-R652, 1994.
30. Zagon, I. S., Y. Wu, and P. J. McLaughlin. Opioid growth factor-dependent DNA synthesis in the neonatal rat aorta. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R22-R32, 1996.